0001053310-12-000001.txt : 20120629 0001053310-12-000001.hdr.sgml : 20120629 20120629183237 ACCESSION NUMBER: 0001053310-12-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120627 FILED AS OF DATE: 20120629 DATE AS OF CHANGE: 20120629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY E GERALD CENTRAL INDEX KEY: 0001053310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 12937066 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-06-27 0 0001016504 INTEGRATED BIOPHARMA INC INBP.OB 0001053310 KAY E GERALD 225 LONG AVENUE HILLSIDE NJ 07205 1 1 1 0 CEO AND PRESIDENT COMMON STOCK 2012-06-27 4 S 0 250000 0.09 D 5270444 D Shares disposed of in connection with a refinancing transaction involving the issuer. The Reporting Person has no preset intent to dispose of additional shares. Includes (i) 819,629 shares of common stock held by EGK LLC, of which the Reporting Person is the manager; and (ii) 307,888 shares of common stock issuable upon exercise of presently exercisable stock options; the Reporting Person shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Sheppard with respect to 169,358 shares of common stock. /S/ E. GERALD KAY 2012-06-29